Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/09/2000 | DE19919121A1 Multimeric cytomegalovirus antigen useful as an immunoassay reagent, and which comprises at least two p52 peptide sequences |
11/09/2000 | CA2407714A1 Expression of heparin-binding protein in recombinant mammalian cells |
11/09/2000 | CA2377131A1 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
11/09/2000 | CA2373225A1 Oligonucleotides having a-dna form and b-dna form conformational geometry |
11/09/2000 | CA2373045A1 Gene therapy using tgf-.beta. |
11/09/2000 | CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
11/09/2000 | CA2373018A1 Novel cellular regulation factor tto 20 |
11/09/2000 | CA2372923A1 Dna encoding snorf36a and snorf36b receptors |
11/09/2000 | CA2372907A1 Zymogen activation system |
11/09/2000 | CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway |
11/09/2000 | CA2372741A1 Glucose dehydrogenase |
11/09/2000 | CA2372235A1 Conserved neisserial antigens |
11/09/2000 | CA2372221A1 Methods for producing recombinant insulin from novel fusion proteins |
11/09/2000 | CA2372192A1 Lim mineralization protein splice variants |
11/09/2000 | CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia |
11/09/2000 | CA2372022A1 Traf5 knockout mouse |
11/09/2000 | CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
11/09/2000 | CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
11/09/2000 | CA2371702A1 Meg-3 protein |
11/09/2000 | CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
11/09/2000 | CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
11/09/2000 | CA2371442A1 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
11/09/2000 | CA2371032A1 Neisseria genomic sequences and methods of their use |
11/09/2000 | CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
11/09/2000 | CA2370451A1 Cloned and engineered plants and methods of use for bioremediation |
11/09/2000 | CA2370436A1 Microbial protein expression system |
11/09/2000 | CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1 |
11/09/2000 | CA2370261A1 Process to create biomolecule arrays on metal surfaces |
11/09/2000 | CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease |
11/09/2000 | CA2370119A1 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
11/09/2000 | CA2370117A1 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
11/09/2000 | CA2370111A1 Optical probes and assays |
11/09/2000 | CA2369964A1 Pesticidal fusions |
11/09/2000 | CA2369747A1 Mutant human cd80 and compositions for and methods of making and using the same |
11/09/2000 | CA2369371A1 Death domain containing receptor 5 |
11/09/2000 | CA2368581A1 Detection using degradation of a tagged sequence |
11/09/2000 | CA2368194A1 Adeno-associated virus-delivered ribozyme compositions and methods of use |
11/09/2000 | CA2365591A1 Herbicide resistant plants |
11/09/2000 | CA2365590A1 Herbicide resistant plants |
11/09/2000 | CA2365440A1 Human ion channel proteins |
11/09/2000 | CA2365285A1 Novel genes encoding wheat starch synthases and uses therefor |
11/09/2000 | CA2365278A1 Tumour-associated antigen |
11/09/2000 | CA2338799A1 Protein c derivatives |
11/09/2000 | CA2335966A1 Method for inducing growth and enhancing survival of nervous tissue |
11/08/2000 | EP1050588A1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device |
11/08/2000 | EP1050587A2 Generation and amplification of nucleic acids from ribonucleic acids |
11/08/2000 | EP1050586A1 Method for transferring gene into germ cell |
11/08/2000 | EP1050585A2 PROMOTER AND REGULATOR SEQUENCES $i(Ha ds10 G1): A GENE LEA OF SUNFLOWER EXPRESSED EXCLUSIVELY IN SEEDS FROM THE MATURATION PHASE |
11/08/2000 | EP1050584A1 Recombinant lysophosphatidic acid phosphatase |
11/08/2000 | EP1050583A1 Hiv infection inhibitors |
11/08/2000 | EP1050582A2 Recombinant microorganisms expressing small rubber particle-associated protein |
11/08/2000 | EP1050581A1 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or accelerators of these enzymes |
11/08/2000 | EP1050580A1 Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same |
11/08/2000 | EP1050306A1 CYTOKINE INDUCERS COMPRISING M161Ag |
11/08/2000 | EP1050209A2 Process for transformation of mature trees of eucalyptus plants |
11/08/2000 | EP1049810A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53 |
11/08/2000 | EP1049809A2 EF-Tu mRNA AS A MARKER FOR VIABILITY OF BACTERIA |
11/08/2000 | EP1049806A1 Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter |
11/08/2000 | EP1049805A2 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
11/08/2000 | EP1049802A1 Fluorimetric detection system of a nucleic acid |
11/08/2000 | EP1049801A1 Method for isolating and purifying nucleic acids on surfaces |
11/08/2000 | EP1049800A1 Asthma related genes |
11/08/2000 | EP1049799A1 Antimicrobial compounds |
11/08/2000 | EP1049797A1 Regulation of fungal gene expression |
11/08/2000 | EP1049796A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development |
11/08/2000 | EP1049793A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
11/08/2000 | EP1049792A1 Methods for recovering polypeptides from plants and portions thereof |
11/08/2000 | EP1049791A1 Methods and composition for modulating flavonoid content |
11/08/2000 | EP1049790A1 Process for making desired polypeptides in yeast |
11/08/2000 | EP1049789A1 An autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element |
11/08/2000 | EP1049788A2 Protein expression in baculovirus vector expression systems |
11/08/2000 | EP1049787A1 Multipurpose antibody derivatives |
11/08/2000 | EP1049786A2 Human orthologues of wart |
11/08/2000 | EP1049785A2 Methods and compositions for modifying levels of secondary metabolic compounds in plants |
11/08/2000 | EP1049784A1 POLYHYDROCYALKANOATE BIOSYNTHESIS-RELATED GENES DERIVED FROM $i(ALCALIGENES LATUS) |
11/08/2000 | EP1049783A2 Frozen food product |
11/08/2000 | EP1049782A1 Mutants of il-16, processes for their production, and their use |
11/08/2000 | EP1049781A1 Human chemokine and its use for detection and treatment of breast disease |
11/08/2000 | EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
11/08/2000 | EP1049779A2 Lh-receptor gene promoter for tissue-specific gene expression |
11/08/2000 | EP1049778A2 Recombinant proteins derived from hgf and msp |
11/08/2000 | EP1049777A1 Acpl dna and polypeptides |
11/08/2000 | EP1049776A1 Phagocytosis genes and uses thereof |
11/08/2000 | EP1049775A1 Human btrcp protein |
11/08/2000 | EP1049774A2 Promoter regions of the mouse and human telomerase rna component genes |
11/08/2000 | EP1049773A1 Inhibition of cytokine production |
11/08/2000 | EP1049772A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
11/08/2000 | EP1049771A2 Transgenic non-human mammal, a method for the production thereof, and the utilization thereof |
11/08/2000 | EP1049770A1 Secreted proteins and polynucleotides encoding them |
11/08/2000 | EP1049769A2 Mutant herpes simplex viruses and uses thereof |
11/08/2000 | EP1049767A1 A transgenic rabbit that expresses a functional human lipoprotein (a) |
11/08/2000 | EP1049766A1 Method and device for cell lysis |
11/08/2000 | EP1049744A1 Asymmetric cyanine dye quenchers |
11/08/2000 | EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin |
11/08/2000 | EP1049714A1 Secreted proteins and polynucleotides encoding them |
11/08/2000 | EP1049713A2 Antifreeze protein |
11/08/2000 | EP1049708A1 Meth1 and meth2 polynucleotides and polypeptides |
11/08/2000 | EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN |
11/08/2000 | EP1049487A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
11/08/2000 | EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |